Effects of short-course immunosuppression on chimerism and tolerance indhuced by bone marrow transplantation without cytoreductive conditioning

FENG You-gang,ZENG Fu-qing,WANG Guang-ming,LI Ai-ling,HAO Jie,LI Chong,YUAN Guo-hong,GAO Xiang,XIE Shu-sheng
DOI: https://doi.org/10.3760/j:issn:0254-5101.2006.10.004
2006-01-01
Abstract:Objective To analyse the effects of conventional immunosuppressive drugs on chimerism and tolerance induced by allogeneic bone marrow transplantation(BMT)in combination with CTLA4-FasL gene transfer mediated by adenovirus.Methods C57BL/6(H-2~b,B6)mice received BALB/c(H-2~d)mice skin transplanta- tion,followed by combined injection of adenovims vector encoding CTLA4-FasL gene and bone marrow cells (BMC)via tail vein.Cyclosporin A(CsA)or mycophenolate mofetil(MMF)or both was administered daffy from day 0 to day 28 post-transplantation.Then,survival of the skin grafts were observed,the level of Vβ11~+ T cells and donor cells in peripheral blood leucocyte(PBL)of recipient were tested by flow cytometry,the tolerance to do- nor antigen was evaluated through one-way MLR.Results In our non-eytoreductive model using BMT and CTLA4-FasL gene transfer,short-couse immunosuppression facilitated early engraftment of donor bone marrow, while the mixed ehimerism in peripheral blood of B6 recipients treated with CsA or both CsA and MMF were re- duced to very low level on day 140 after skin transplantation;when compared with B6 recipients treated with MMF or without immunosuppressive drugs,the mean survival time(MST)of skin allografts of those mice treated with CsA or both CsA and MMF was significantly reduced,and the levels of Vβ11~+T cells were higher;furthermore, B6 recipients treated with CsA or both CsA and MMF showed no tolerance to donor antigen.Conclusion Immu- nesuppressive regime containing CsA could abrogate the induction of long-lasting mixed chimerism and the devdop- ment of tolerance in non-cytoreductive model using BMT and CILA4-FasL gene transfer,owing to negative effect of CsA on peripheral deletion of donor-specific T cells.However,MMF was compatible with our non-cytoreductie protocol.
What problem does this paper attempt to address?